Search - tctmd.com

Displaying 301 - 320 of 520

Sort: Relevancy | Date

News Daily News

FDA Approves Novel Stent Graft for Dialysis-Access Stenosis

January 27, 2014

News Daily News

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Yael L. Maxwell

January 01, 2014

News Daily News

Ultrasound-Accelerated Thrombolysis More Effective Than Heparin Alone for Intermediate PE

January 01, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

初期研究显示利伐沙班拮抗剂安全、有效

December 30, 2013

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

December 30, 2013

Presentation

A Phase 2 Placebo-Controlled Trial Demonstrating Reversal of Rivaroxaban-induced Anticoagulation

Presenter: Mark Crowther

December 22, 2013

News Daily News

稳定型患者在停用氯吡格雷后未出现反弹效应

December 05, 2013

News Daily News

Sin Efecto Rebote tras Interrumpir Clopidogrel en Pacientes Estables

December 05, 2013

News Daily News

No Rebound Effect after Clopidogrel Cessation in Stable Patients

December 05, 2013

News Daily News

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

December 05, 2013

News Daily News

Warfarin Offers Poor Protection Against Radial Occlusion After Transradial Angiography

November 26, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Presenter: Harvey White

October 31, 2013

Presentation TCT 2013

Case #1: Fibrinolysis or Aggressive Pre-hospital Anticoagulation to Prevent Complications During Long Distance Transfer?

Presenter: Peter Clemmensen

October 31, 2013

Presentation TCT 2013

Anticoagulation For Prosthetic Valves: Warfarin for Mechanical Valves

Presenter: Bernard Gersh

October 31, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Advertisement

FDA Approves Novel Stent Graft for Dialysis-Access Stenosis

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Ultrasound-Accelerated Thrombolysis More Effective Than Heparin Alone for Intermediate PE

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

初期研究显示利伐沙班拮抗剂安全、有效

Rivaroxaban Antidote Appears Safe, Effective in Early Study

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

A Phase 2 Placebo-Controlled Trial Demonstrating Reversal of Rivaroxaban-induced Anticoagulation

稳定型患者在停用氯吡格雷后未出现反弹效应

Sin Efecto Rebote tras Interrumpir Clopidogrel en Pacientes Estables

No Rebound Effect after Clopidogrel Cessation in Stable Patients

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

Warfarin Offers Poor Protection Against Radial Occlusion After Transradial Angiography

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Case #1: Fibrinolysis or Aggressive Pre-hospital Anticoagulation to Prevent Complications During Long Distance Transfer?

Anticoagulation For Prosthetic Valves: Warfarin for Mechanical Valves

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content